129 related articles for article (PubMed ID: 7557616)
1. Tumor vascularity--a novel prognostic factor in advanced cervical carcinoma.
Schlenger K; Höckel M; Mitze M; Schäffer U; Weikel W; Knapstein PG; Lambert A
Gynecol Oncol; 1995 Oct; 59(1):57-66. PubMed ID: 7557616
[TBL] [Abstract][Full Text] [Related]
2. Association between host tissue vascularity and the prognostically relevant tumor vascularity in human cervical cancer.
Höckel S; Schlenger K; Vaupel P; Höckel M
Int J Oncol; 2001 Oct; 19(4):827-32. PubMed ID: 11562762
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
[TBL] [Abstract][Full Text] [Related]
4. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.
Hockel M; Schlenger K; Aral B; Mitze M; Schaffer U; Vaupel P
Cancer Res; 1996 Oct; 56(19):4509-15. PubMed ID: 8813149
[TBL] [Abstract][Full Text] [Related]
5. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
[TBL] [Abstract][Full Text] [Related]
6. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
[TBL] [Abstract][Full Text] [Related]
7. The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma: correlation of results from hematoxylin and eosin staining with results from immunostaining for factor VIII-related antigen.
Obermair A; Wanner C; Bilgi S; Speiser P; Reisenberger K; Kaider A; Kainz C; Leodolter S; Breitenecker G; Gitsch G
Cancer; 1998 Feb; 82(4):689-96. PubMed ID: 9477101
[TBL] [Abstract][Full Text] [Related]
8. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
[TBL] [Abstract][Full Text] [Related]
9. Expression of thymidine phosphorylase in human cervical cancer.
Hata K; Takebayashi Y; Iida K; Fujiwaki R; Fukumoto M; Miyazaki K
Anticancer Res; 1999; 19(1B):709-16. PubMed ID: 10216481
[TBL] [Abstract][Full Text] [Related]
10. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
[TBL] [Abstract][Full Text] [Related]
11. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
12. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
[TBL] [Abstract][Full Text] [Related]
13. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
Stock RG; Chen AS; Karasek K
Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
[TBL] [Abstract][Full Text] [Related]
14. Different angiogenic pathways in human cervical cancers.
Tokumo K; Kodama J; Seki N; Nakanishi Y; Miyagi Y; Kamimura S; Yoshinouchi M; Okuda H; Kudo T
Gynecol Oncol; 1998 Jan; 68(1):38-44. PubMed ID: 9454658
[TBL] [Abstract][Full Text] [Related]
15. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy.
Harrison TA; Sevin BU; Koechli O; Nguyen HN; Averette HE; Penalver M; Donato DM; Nadji M
Gynecol Oncol; 1993 Sep; 50(3):310-5. PubMed ID: 8406193
[TBL] [Abstract][Full Text] [Related]
16. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
[TBL] [Abstract][Full Text] [Related]
17. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
[TBL] [Abstract][Full Text] [Related]
18. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
19. A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma.
Sakuragi N; Takeda N; Hareyama H; Fujimoto T; Todo Y; Okamoto K; Takeda M; Wada Si; Yamamoto R; Fujimoto S
Cancer; 2000 Jun; 88(11):2578-83. PubMed ID: 10861436
[TBL] [Abstract][Full Text] [Related]
20. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years.
Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
Gynecol Oncol; 2001 May; 81(2):133-7. PubMed ID: 11330939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
